8-K//Current report
ANTARES PHARMA, INC. 8-K
Accession 0001016169-22-000022
CIK 0001016169operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:10 AM ET
Size
674.8 KB
Accession
0001016169-22-000022
Documents
- 8-Katrs-20220303.htmPrimary
8-K
- EX-99.1atrs-20220303x8kexx991.htm
EX-99.1
- EX-101.SCHatrs-20220303.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABatrs-20220303_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREatrs-20220303_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICatrs-20220303_g1.jpg
GRAPHIC
- GRAPHICgbzjl4uq45ct000001.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLatrs-20220303_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001016169-22-000022-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001016169
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:10 AM ET
- Size
- 674.8 KB